PACIRA BIOSCIENCES, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
PACIRA BIOSCIENCES, INC. (PCRX) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2026-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2026-03-31 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2025-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2025-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2025 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2024 was $0.00.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2023 was -$200.00K.
- PACIRA BIOSCIENCES, INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2022 was -$200.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $0.00 10-Q · filed 2025-11-06 | -$100.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | -$100.00K derived: sum of 3 quarters · filed 2026-08-04 | -$100.00K derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | -$100.00K derived: sum of 2 quarters · filed 2026-04-30 | -$100.00K derived: sum of 3 quarters · filed 2026-04-30 | $0.00 derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$100.00K derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $100.00K derived: sum of 2 quarters · filed 2025-11-06 | $100.00K 10-Q · filed 2025-11-06 | -$100.00K 10-Q · filed 2024-11-06 | -$300.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $100.00K 10-Q · filed 2025-08-05 | -$100.00K 10-Q · filed 2024-07-30 | -$300.00K derived: sum of 3 quarters · filed 2026-02-26 | -$300.00K derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | -$400.00K derived: sum of 2 quarters · filed 2026-02-26 | -$400.00K derived: sum of 3 quarters · filed 2026-02-26 | -$400.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$400.00K derived: sum of 2 quarters · filed 2026-02-26 | -$400.00K derived: sum of 3 quarters · filed 2026-02-26 | -$200.00K 10-K · filed 2026-02-26 | $200.00K 10-K · filed 2024-02-29 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $200.00K 10-Q · filed 2024-11-06 | $300.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $200.00K 10-Q · filed 2024-07-30 | $300.00K derived: sum of 3 quarters · filed 2025-02-27 | $300.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-07 | $300.00K derived: sum of 2 quarters · filed 2025-02-27 | $300.00K derived: sum of 3 quarters · filed 2025-02-27 | $300.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $100.00K derived: sum of 2 quarters · filed 2025-02-27 | $100.00K derived: sum of 3 quarters · filed 2025-02-27 | -$200.00K 10-K · filed 2025-02-27 | $200.00K 10-K · filed 2023-02-28 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | -$300.00K 10-Q · filed 2023-11-02 | $300.00K 10-Q · filed 2022-11-03 | -$500.00K derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$300.00K 10-Q · filed 2023-08-02 | -$500.00K derived: sum of 3 quarters · filed 2024-02-29 | -$351.00K derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | -$300.00K 10-Q · filed 2023-05-03 | -$500.00K derived: sum of 2 quarters · filed 2024-02-29 | -$351.00K derived: sum of 3 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$51.00K derived: sum of 2 quarters · filed 2024-02-29 | -$100.00K 10-K · filed 2024-02-29 | $100.00K 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $100.00K 10-Q · filed 2022-11-03 | $54.00K 10-Q · filed 2021-11-03 | ||||
| 2021-06-30 | -$49.00K 10-Q · filed 2021-08-03 | ||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |